Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription 18.04.2022 8 Am J Cardiol 4 Am J Med 2 Ann Intern Med 1 Ann Thorac Surg 1 Arterioscler Thromb Vasc Biol 3 Atherosclerosis 1 BMJ 2 Circ Cardiovasc Imaging 4 Circ Cardiovasc Interv 28 Circ J 2 Circulation 1 Clin Cardiol 3 Clin Chem 1 Dtsch Med Wochenschr 1 Heart 11 Int J Cardiol 6 J Am Coll Cardiol 2 J Cardiovasc Pharmacol 1 J Mol Cell Cardiol 1 J Thorac Cardiovasc Surg 1 Mayo Clin Proc 7 PLoS One 5 Prog Cardiovasc Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. AHMED AM, Tabi M, Wiley BM, Vallabhajosyula S, et al
   Outcomes Associated With Cardiac Arrest in Patients in the Cardiac Intensive Care Unit With Cardiogenic Shock.
   Am J Cardiol. 2022;169:1-9.
   PubMed         Abstract available
   
   
2. ELBADAWI A, Abdelghany M, Dang A, Omer MA, et al
   Transcatheter Mitral Valve Implantation In Patients With Chronic Kidney Disease.
   Am J Cardiol. 2022 Jan 18. pii: S0002-9149(21)01275.
   PubMed         Abstract available
   
   
3. SCOTT-HERRIDGE JA, McIntyre WF, Hiebert BM, Ducas J, et al
   Does a Heart Team Improve Clinical Outcomes?
   Am J Cardiol. 2022;169:120-126.
   PubMed         Abstract available
   
   
4. CASE BC, Rosenfeld B, Shea C, Rappaport H, et al
   Implications of COVID-19 Vaccination on Hospital Encounters and Outcomes.
   Am J Cardiol. 2022;170:105-111.
   PubMed         Abstract available
   
   
5. SHARMA SP, Manintveld OC, Budde RPJ, Hirsch A, et al
   Gender Differences in Patients With Stable Chest Pain.
   Am J Cardiol. 2022;171:84-90.
   PubMed         Abstract available
   
   
6. VAVURANAKIS MA, Jones SR, Ziogos E, Blaha MJ, et al
   The Trajectory of Lipoprotein(a) During the Peri- and Early Postinfarction Period and the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition.
   Am J Cardiol. 2022;171:1-6.
   PubMed         Abstract available
   
   
7. ROBERTS CS, Roberts CC, Roberts WC
   Cardiac Findings at Necropsy in Acute Type A Aortic Dissection.
   Am J Cardiol. 2022;170:155-159.
   PubMed         Abstract available
   
   
8. FISCHER P, Blumenauer D, Egger F, Fikenzer S, et al
   Effects of Medical Face Masks on Physical Performance in Patients With Coronary Artery Disease or Hypertension.
   Am J Cardiol. 2022 Apr 10. pii: S0002-9149(22)00234.
   PubMed         Abstract available
   
   

   
   Am J Med

9. THINDA N, Ambrose JA, Bhullar A, Huang S, et al
   New Precordial T Wave Inversions in Hospitalized Patients.
   Am J Med. 2022;135:517-523.
   PubMed         Abstract available
   
   
10. YAGUCHI Y, Fujihara K, Yamada MH, Matsubayashi Y, et al
    Impact of Medication Adherence and Glycemic Control on the Risk of Micro/Macrovascular Diseases in Patients with Diabetes.
    Am J Med. 2021 Nov 16. pii: S0002-9343(21)00731.
    PubMed         Abstract available
    
    
11. VITALIS A, Nirantharakumar K, Thayakaran R, Vohra RK, et al
    THE IMPACT OF ATRIAL FIBRILLATION ON OUTCOMES OF PERIPHERAL ARTERIAL DISEASE: ANALYSIS OF ROUTINELY COLLECTED PRIMARY CARE DATA.
    Am J Med. 2021 Nov 15. pii: S0002-9343(21)00733.
    PubMed         Abstract available
    
    
12. WYLIE LE, Waterbrook AL, Dalen JE
    Are Statins Indicated in Senior Citizens? A Review of Statin Therapy in the Elderly.
    Am J Med. 2022;135:426-429.
    PubMed         Abstract available
    
    

    
    Ann Intern Med

13. BACH RG
    DAPT de-escalation from ticagrelor to clopidogrel 1 mo after PCI for acute MI reduced net clinical events at 1 y.
    Ann Intern Med. 2022;175:JC27.
    PubMed         Abstract available
    
    
14. LARDARO T, Hunter BR
    In suspected or provisionally diagnosed ACS, early CTCA did not reduce mortality or nonfatal MI at 1 y.
    Ann Intern Med. 2022;175:JC20.
    PubMed         Abstract available
    
    

    
    Ann Thorac Surg

15. KINOSHITA T, Asai T, Hachiro K, Suzuki T, et al
    Extended Sandwich Patch Technique via Right Ventriculotomy for Acute Ventricular Septal Rupture.
    Ann Thorac Surg. 2022;113:1200-1207.
    PubMed         Abstract available
    
    

    
    Arterioscler Thromb Vasc Biol

16. DUELL PB, Welty FK, Miller M, Chait A, et al
    Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association.
    Arterioscler Thromb Vasc Biol. 2022 Apr 14:101161ATV0000000000000153.
    PubMed         Abstract available
    
    

    
    Atherosclerosis

17. DZAYE O, Razavi AC, Michos ED, Mortensen MB, et al
    Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and FOURIER trial.
    Atherosclerosis. 2022;347:70-76.
    PubMed         Abstract available
    
    
18. JUKEMA RA, de Winter RW, van Diemen PA, Driessen RS, et al
    The relation of RAAS activity and endothelin-1 levels to coronary atherosclerotic burden and microvascular dysfunction in chest pain patients.
    Atherosclerosis. 2022;347:47-54.
    PubMed         Abstract available
    
    
19. AHMED AI, Raggi P, Al-Mallah MH
    Primary vs. secondary prevention and coronary artery calcium: Shades of grey.
    Atherosclerosis. 2022;347:68-69.
    PubMed        
    
    

    
    BMJ

20. HARSKAMP RE, Fanaroff AC, Zhen SW, Sawe HR, et al
    Recognising acute coronary syndrome.
    BMJ. 2022;377:e069591.
    PubMed        
    
    

    
    Circ Cardiovasc Imaging

21. TAQUETI VR
    Calcified Coronary Plaque and Flow Reserve: Nonredundant and Complimentary Markers of Cardiovascular Prognosis.
    Circ Cardiovasc Imaging. 2022 Apr 13:101161CIRCIMAGING122014126.
    PubMed        
    
    
22. PATEL KK, Peri-Okonny PA, Qarajeh R, Patel FS, et al
    Prognostic Relationship Between Coronary Artery Calcium Score, Perfusion Defects, and Myocardial Blood Flow Reserve in Patients With Suspected Coronary Artery Disease.
    Circ Cardiovasc Imaging. 2022 Apr 13:101161CIRCIMAGING121012599.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

23. TOMEY MI, Tamis-Holland JE, Cohen MG
    Significance of Insignificant Left Main Disease.
    Circ Cardiovasc Interv. 2022 Apr 12:101161CIRCINTERVENTIONS122012001.
    PubMed        
    
    
24. VELAGALETI RS, Vetter J, Parker R, Kurgansky KE, et al
    Change in Left Ventricular Ejection Fraction With Coronary Artery Revascularization and Subsequent Risk for Adverse Cardiovascular Outcomes.
    Circ Cardiovasc Interv. 2022 Apr 12:101161CIRCINTERVENTIONS121011284.
    PubMed         Abstract available
    
    
25. BANGALORE S, Spertus JA, Stevens SR, Jones PG, et al
    Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial.
    Circ Cardiovasc Interv. 2022 Apr 12:CIRCINTERVENTIONS121010925.
    PubMed         Abstract available
    
    
26. SCHELLER B, Rissanen TT, Farah A, Ohlow MA, et al
    Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial.
    Circ Cardiovasc Interv. 2022 Apr 12:101161CIRCINTERVENTIONS121011569.
    PubMed         Abstract available
    
    

    
    Circ J

27. HIRAYA D, Sato A, Hoshi T, Sakai S, et al
    Additional Effect of Coronary High-Intensity Plaque on T1-Weighted Magnetic Resonance Imaging With Circulating Malondialdehyde-Modified Low-Density Lipoprotein on Cardiac Events.
    Circ J. 2021;85:2032-2039.
    PubMed         Abstract available
    
    
28. PLOUMEN EH, Buiten RA, Zocca P, Doggen CJ, et al
    First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial.
    Circ J. 2021;85:1983-1990.
    PubMed         Abstract available
    
    
29. SHINOHARA H, Shimpo M, Watanabe H, Toriumi S, et al
    Intravascular Ultrasound-Validated Mechanical Stress of the Aorta on Anomalous Origin of Coronary Artery- A Possible Sign of Angina.
    Circ J. 2021;85:2120.
    PubMed        
    
    
30. TAKAHASHI T, Latib A, Kobayashi Y
    Complementary Assessment by Hybrid Intravascular Ultrasound-Optical Coherence Tomography Catheter After Implantation of a New-Generation Drug-Eluting Stent.
    Circ J. 2021;85:2119.
    PubMed        
    
    
31. OKABE K, Ohya M, Ikuta A, Takamatsu M, et al
    Outcomes at 1 Year of Non-Left Main Trunk Bifurcation Lesions Treated With a 2-Stent Strategy Using Newer-Generation Everolimus-Eluting Stents.
    Circ J. 2021;85:1972-1980.
    PubMed         Abstract available
    
    
32. OTAKE H
    Stent Edge Restenosis- An Inevitable Drawback of Stenting?
    Circ J. 2021;85:1969-1971.
    PubMed        
    
    
33. TAKAHASHI T, Kobayashi Y, Chau ML, Latib A, et al
    Zero-Contrast Transcatheter Aortic Valve-in-Valve Implantation Using Intravascular Ultrasound to Evaluate Coronary Obstruction Risk.
    Circ J. 2021;86:168.
    PubMed        
    
    
34. OTOWA K, Chikata A, Maruyama M, Usuda K, et al
    Rapidly Progressive Infected Coronary Artery Aneurysm.
    Circ J. 2021;85:2246.
    PubMed        
    
    
35. MATSUZAWA Y, Kosuge M, Fukui K, Suzuki H, et al
    Present and Future Status of Cardiovascular Emergency Care System in Urban Areas of Japan- Importance of Prehospital 12-Lead Electrocardiogram.
    Circ J. 2022;86:591-599.
    PubMed         Abstract available
    
    
36. HYUN J, Kim AR, Lee SE, Hong JA, et al
    Vasoactive-Inotropic Score as a Determinant of Timely Initiation of Venoarterial Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.
    Circ J. 2022;86:687-694.
    PubMed         Abstract available
    
    
37. KAWASAKI T
    Prospects for the Combined Evaluation of Circulating Malondialdehyde-Modified Low-Density Lipoprotein Measurement and High-Intensity Plaque on T1-Weighted Cardiac Magnetic Resonance Angiography in the Prediction of Cardiovascular Events.
    Circ J. 2021;85:2040-2042.
    PubMed        
    
    
38. JIMBA T, Ikutomi M, Tsukamoto A, Matsushita M, et al
    Effect of Hinge Motion on Stent Edge-Related Restenosis After Right Coronary Artery Treatment in the Current Drug-Eluting Stent Era.
    Circ J. 2021;85:1959-1968.
    PubMed         Abstract available
    
    
39. TANAKA Y, Matsuyama S, Tada H, Hayashi K, et al
    Association of Lower Urinary Tract Symptoms Based on the International Prostate Symptom Score and Cardiovascular Disease.
    Circ J. 2021;85:2092-2099.
    PubMed         Abstract available
    
    
40. KAINUMA S, Toda K, Daimon T, Miyagawa S, et al
    Bilateral Internal Thoracic Artery Grafting Improves Survival for Severe Left Ventricular Dysfunction and Diabetes.
    Circ J. 2021;85:1991-2001.
    PubMed         Abstract available
    
    
41. NATSUAKI M, Morimoto T, Shiomi H, Kadota K, et al
    Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary Intervention.
    Circ J. 2021;85:1928-1941.
    PubMed         Abstract available
    
    
42. KEECH AC, Oyama K, Sever PS, Tang M, et al
    Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects- A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial.
    Circ J. 2021;85:2063-2070.
    PubMed         Abstract available
    
    
43. IIJIMA R, Nakamura M
    Optimal Revascularization Strategy for Acute Coronary Syndromes With High Bleeding Risk- It Is Hard to Please All Parties.
    Circ J. 2021;85:1942-1943.
    PubMed        
    
    
44. IWAI S, Watanabe M, Okamura A, Kyodo A, et al
    Prognostic Impact of Calcified Plaque Morphology After Drug Eluting Stent Implantation- An Optical Coherence Tomography Study.
    Circ J. 2021;85:2019-2028.
    PubMed         Abstract available
    
    
45. KANG J, Han JK, Yang HM, Park KW, et al
    Comparison of 2-Stenting Strategies Depending on Sequence or Technique for Bifurcation Lesions in the Second-Generation Drug-Eluting Stent Era- Analysis From the COBIS (Coronary Bifurcation Stenting) III Registry.
    Circ J. 2021;85:1944-1955.
    PubMed         Abstract available
    
    
46. KAWAMOTO S
    Clinical Impacts of Myocardial Injury After Noncardiac Surgery on Younger Generation.
    Circ J. 2021;85:2089-2091.
    PubMed        
    
    
47. KAWAMURA I, Tanigaki T, Omori H, Mizukami T, et al
    Stress Myocardial Perfusion Imaging Interpretation From the Viewpoint of Fractional Flow Reserve.
    Circ J. 2021;85:2043-2049.
    PubMed         Abstract available
    
    
48. KOHSAKA S, Fukushima K, Watanabe I, Manabe S, et al
    Contemporary Management of Stable Coronary Artery Disease- Implications of the ISCHEMIA Trial.
    Circ J. 2021;85:1919-1927.
    PubMed         Abstract available
    
    
49. HACHIRO K, Kinoshita T, Suzuki T, Asai T, et al
    Bilateral Internal Thoracic Artery Grafting in Hemodialysis Patients.
    Circ J. 2021;85:2004-2010.
    PubMed         Abstract available
    
    
50. WAKABAYASHI H, Taki J, Mori H, Hiromasa T, et al
    Visualization of Dynamic Expression of Myocardial Sigma-1 Receptor After Myocardial Ischemia and Reperfusion Using Radioiodine-Labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (OI5V) Imaging.
    Circ J. 2021;85:2102-2108.
    PubMed         Abstract available
    
    
51. TOMOI Y, Kuramitsu S, Shinozaki T, Hiramori S, et al
    Temporal Course of Vascular Response After Fluoropolymer Paclitaxel-Eluting Stent Implantation for Femoropopliteal Artery Lesions.
    Circ J. 2021;85:2159-2165.
    PubMed         Abstract available
    
    
52. SAKU K, Nakata J
    How Should We Develop New Risk Scores for Cardiogenic Shock?
    Circ J. 2022;86:695-698.
    PubMed        
    
    
53. NAKAMURA M, Yaku H, Ako J, Arai H, et al
    JCS/JSCVS 2018 Guideline on Revascularization of Stable Coronary Artery Disease.
    Circ J. 2022;86:477-588.
    PubMed        
    
    
54. SIBBALD M, Pinilla-Echeverri N, Alameer M, Chavarria J, et al
    Using Optical Coherence Tomography to Identify Lipid and Its Impact on Interventions and Clinical Events- A Scoping Review.
    Circ J. 2021;85:2053-2062.
    PubMed         Abstract available
    
    

    
    Circulation

55. JONE PN, John A, Oster ME, Allen K, et al
    SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Apr 11:101161CIR0000000000001064.
    PubMed         Abstract available
    
    
56. ZHANG J, Liang R, Wang K, Zhang W, et al
    Novel CaMKII-delta Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth.
    Circulation. 2022;145:1154-1168.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

57. MOTAMED N, Ajdarkosh H, Karbalaie Niya MH, Panahi M, et al
    Scoring systems of metabolic syndrome and prediction of cardiovascular events: A population based cohort study.
    Clin Cardiol. 2022 Apr 14. doi: 10.1002/clc.23827.
    PubMed         Abstract available
    
    

    
    Clin Chem

58. LIU L, Consagra W, Cai X, Mathias A, et al
    Sex-Specific Absolute Delta Thresholds for High-Sensitivity Cardiac Troponin T.
    Clin Chem. 2022;68:441-449.
    PubMed         Abstract available
    
    
59. CULLEN L, Greenslade J, Parsonage W
    Chest Pain Assessment: What Is Our Endgame?
    Clin Chem. 2022;68:261-263.
    PubMed        
    
    
60. SORENSEN NA, Gossling A, Neumann JT, Hartikainen TS, et al
    Diagnostic Validation of a High-Sensitivity Cardiac Troponin I Assay.
    Clin Chem. 2021;67:1230-1239.
    PubMed         Abstract available
    
    

    
    Dtsch Med Wochenschr

61. MICHELS G, Fuchs N, Lentes IM
    [21-year-old patient with ST-segment elevation myocardial infarction?]
    Dtsch Med Wochenschr. 2022;147:449-450.
    PubMed        
    
    

    
    Heart

62. SANZ-SANCHEZ J, Stefanini GG
    Timing and completeness of revascularisation in acute coronary syndromes.
    Heart. 2022;108:648-656.
    PubMed        
    
    

    
    Int J Cardiol

63. KOECHLIN L, Boeddinghaus J, Nestelberger T, Lopez-Ayala P, et al
    Lower diagnostic accuracy of hs-cTnI in patients with prior coronary artery bypass grafting.
    Int J Cardiol. 2022;354:1-6.
    PubMed         Abstract available
    
    
64. GRAGNANO F, Cesaro A, Pelliccia F, Limongelli G, et al
    Early-onset MINOCA: Prognostic implications and considerations for practice.
    Int J Cardiol. 2022;354:14-16.
    PubMed        
    
    
65. MA F, Hao J, Zhao J, Liu DY, et al
    Circulating FAM19A5 level is associated with the presence and severity of coronary artery disease.
    Int J Cardiol. 2022;354:50-55.
    PubMed         Abstract available
    
    
66. HITOMI Y, Masaki N, Ishinoda Y, Ido Y, et al
    Effectiveness of the d-ROMs oxidative stress test to predict long-term cardiovascular mortality.
    Int J Cardiol. 2022;354:43-47.
    PubMed         Abstract available
    
    
67. CAO M, Luo H, Li D, Wang S, et al
    Research advances on circulating long noncoding RNAs as biomarkers of cardiovascular diseases.
    Int J Cardiol. 2022;353:109-117.
    PubMed         Abstract available
    
    
68. NANDHAKUMAR V, Pakshirajan B, Chopra A, Anandan H, et al
    Safety and feasibility of intravascular ultrasound guided zero-contrast percutaneous coronary intervention-A prospective study.
    Int J Cardiol. 2022;353:22-28.
    PubMed         Abstract available
    
    
69. D'ASCENZO F, Elia E, de Filippo O, Manai R, et al
    Net clinical benefit of different strategies of dual antiplatelet therapy in elderly patients: Data from the praise registry.
    Int J Cardiol. 2022;353:9-14.
    PubMed         Abstract available
    
    
70. MASSUSSI M, Cipriani A, Meneghin S, De la Cruz N, et al
    Prognostic value of left ventricular blood stasis in patients with acute myocardial infarction: A cardiac magnetic resonance study.
    Int J Cardiol. 2022 Apr 6. pii: S0167-5273(22)00492.
    PubMed         Abstract available
    
    
71. ZHAO Z, Shi Q, Guo Q, Peng L, et al
    Remote ischemic preconditioning can extend the tolerance to extended drug-coated balloon inflation time by reducing myocardial damage during percutaneous coronary intervention.
    Int J Cardiol. 2022;353:3-8.
    PubMed         Abstract available
    
    
72. MANTOVANI A, Bonapace S, Dugo C, Beatrice G, et al
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Feb 12. pii: S0167-5273(22)00248.
    PubMed         Abstract available
    
    
73. SCICALI R
    Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease.
    Int J Cardiol. 2022;353:118.
    PubMed        
    
    

    
    J Am Coll Cardiol

74. PETRAZZINI BO, Chaudhary K, Marquez-Luna C, Forrest IS, et al
    Coronary Risk Estimation Based on Clinical Data in Electronic Health Records.
    J Am Coll Cardiol. 2022;79:1155-1166.
    PubMed         Abstract available
    
    
75. DAVIES JE
    iFR-SWEDEHEART: Answering the Questions of a Decade of Scientific Debate About iFR and FFR.
    J Am Coll Cardiol. 2022;79:975-976.
    PubMed        
    
    
76. NASIR K, DeFilippis A
    Big Data and ASCVD Risk Prediction: Building a Better Mouse Trap?
    J Am Coll Cardiol. 2022;79:1167-1169.
    PubMed        
    
    
77. GOTBERG M, Berntorp K, Rylance R, Christiansen EH, et al
    5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve.
    J Am Coll Cardiol. 2022;79:965-974.
    PubMed         Abstract available
    
    
78. SERAPHIM A, Dowsing B, Rathod KS, Shiwani H, et al
    Quantitative Myocardial Perfusion Predicts Outcomes in Patients With Prior Surgical Revascularization.
    J Am Coll Cardiol. 2022;79:1141-1151.
    PubMed         Abstract available
    
    
79. WONG CCY, Yong ASC, Keech A, Ada C, et al
    Evolution of the Coronary Microcirculation After Restoration of Epicardial Blood Flow in STEMI.
    J Am Coll Cardiol. 2022;79:1127-1128.
    PubMed        
    
    

    
    J Cardiovasc Pharmacol

80. SHAN C, Degryse B, Tolan P, Custaud MA, et al
    Pleiotropic effects of Icariside II on the cardiovascular system: Novel applications of ethnopharmacology in targeting vascular remodelling.
    J Cardiovasc Pharmacol. 2022 Apr 12. pii: 00005344-990000000-00024.
    PubMed        
    
    
81. BAI N, Ma Y, Niu Y, Zhong PY, et al
    Efficacy and safety of de-escalation of antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome: a meta-analysis of randomized clinical trials.
    J Cardiovasc Pharmacol. 2022 Apr 8. pii: 00005344-990000000-00022.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

82. MOTURI S, Ghosh-Choudhary SK, Finkel T
    Cardiovascular disease and the biology of aging.
    J Mol Cell Cardiol. 2022;167:109-117.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

83. FRICKE TA, Buratto E, Thungathurthi K, Schulz A, et al
    Outcomes of the arterial switch operation in patients with inverted coronary artery anatomy.
    J Thorac Cardiovasc Surg. 2022 Mar 16. pii: S0022-5223(22)00326.
    PubMed         Abstract available
    
    

    
    Mayo Clin Proc

84. AHMADI MN, Gill JMR, Stamatakis E
    Association of Changes in Physical Activity and Adiposity With Mortality and Incidence of Cardiovascular Disease: Longitudinal Findings From the UK Biobank.
    Mayo Clin Proc. 2022 Apr 9. pii: S0025-6196(21)00881.
    PubMed         Abstract available
    
    

    
    PLoS One

85. KOTAJARVI J, Tolppanen AM, Hartikainen J, Miettinen H, et al
    Correlation of the disease-specific Canadian Cardiovascular Society (CCS) classification and health-related quality of life (15D) in coronary artery disease patients.
    PLoS One. 2022;17:e0266101.
    PubMed         Abstract available
    
    
86. POWELL AC, Goldstein JP, Long JW, Simmons JD, et al
    The association between provider characteristics and post-catheterization interventions.
    PLoS One. 2022;17:e0266544.
    PubMed         Abstract available
    
    
87. PATEL RS, Denaxas S, Howe LJ, Eggo RM, et al
    Reproducible disease phenotyping at scale: Example of coronary artery disease in UK Biobank.
    PLoS One. 2022;17:e0264828.
    PubMed         Abstract available
    
    
88. ZAFAR A, Drobni ZD, Lei M, Gongora CA, et al
    The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm.
    PLoS One. 2022;17:e0265767.
    PubMed         Abstract available
    
    
89. ERIKSEN E, Herstad J, Pertiwi KR, Tuseth V, et al
    Thrombus characteristics evaluated by acute optical coherence tomography in ST elevation myocardial Infarction.
    PLoS One. 2022;17:e0266634.
    PubMed         Abstract available
    
    
90. DALAH EZ, Obaideen A, Anam S, Alzimami K, et al
    Gender based lung cancer risks for symptomatic coronary artery disease patients undergone cardiac CT.
    PLoS One. 2022;17:e0265609.
    PubMed         Abstract available
    
    
91. JENTZER JC, Wiley BM, Anavekar NS
    Echocardiographic left ventricular stroke work index: An integrated noninvasive measure of shock severity.
    PLoS One. 2022;17:e0262053.
    PubMed         Abstract available
    
    

    
    Prog Cardiovasc Dis

92. MAMATAZ T, Uddin J, Ibn Alam S, Taylor RS, et al
    Effects of cardiac rehabilitation in low-and middle-income countries: A systematic review and meta-analysis of randomised controlled trials.
    Prog Cardiovasc Dis. 2022;70:119-174.
    PubMed         Abstract available
    
    
93. OBRADOVIC D, Freund A, Feistritzer HJ, Sulimov D, et al
    Temporary mechanical circulatory support in cardiogenic shock.
    Prog Cardiovasc Dis. 2021;69:35-46.
    PubMed         Abstract available
    
    
94. FRANKLIN BA, Quindry J
    High level physical activity in cardiac rehabilitation: Implications for exercise training and leisure-time pursuits.
    Prog Cardiovasc Dis. 2022;70:22-32.
    PubMed         Abstract available
    
    
95. LUTZ AH, Forman DE
    Cardiac rehabilitation in older adults: Apropos yet significantly underutilized.
    Prog Cardiovasc Dis. 2022;70:94-101.
    PubMed         Abstract available
    
    
96. HEINDL B, Ramirez L, Joseph L, Clarkson S, et al
    Hybrid cardiac rehabilitation - The state of the science and the way forward.
    Prog Cardiovasc Dis. 2022;70:175-182.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: